+16,554.9%
INTC vs GSK
+1,657.0%
+14,897.9%
-82.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1990-01-01 to 2026-09-08.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.1% | -2.7% | +11.8% | +10.0% |
| 7D | +17.4% | -4.2% | +21.6% | +19.1% |
| 30D | +2.8% | -7.5% | +10.3% | +5.4% |
| 3M | -5.3% | -3.3% | -2.0% | -5.1% |
| 6M | +140.6% | -9.3% | +149.9% | +145.8% |
| YTD | +183.1% | +1.6% | +181.5% | +175.9% |
| 1Y | +326.8% | +25.5% | +301.3% | +281.1% |
| 3Y | +179.4% | +49.3% | +130.2% | +128.2% |
| 5Y | +111.7% | +46.7% | +65.1% | +70.9% |
| 10Y | +253.8% | +76.8% | +177.0% | +163.2% |
| All | +16,554.9% | +1,657.0% | +14,897.9% | +5,325.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1990-01-01 to 2026-09-08: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1990-01-01 to 2026-09-08 analysis · Full analysis span regression · 6 months rolling